Professeur en thérapeutique, Université de Rennes 1 - Université de Rennes
Hallucinogens approved for treating psychiatric disorders: what does the science say?
Dec 28, 2024 07:16 am UTC| Insights & Views Health
Once sidelined in the 1970s, psychedelic substances ranging from esketamine (a ketamine derivative) and psilocybin (the active ingredient in hallucinogenic mushrooms) to MDMA are being reintroduced as potential therapies...
Trump's Bold Moves: A New Era in U.S. Foreign Policy
Trade Truce: Trump Pauses Tariffs as North America Strengthens Borders
South African telescope discovers a giant galaxy that’s 32 times bigger than Earth’s